We are live on ! Find out more
BIA

Biondo Investment Advisors Portfolio holdings

AUM $780M
1-Year Est. Return 21.03%
This Fund
S&P 500
This Quarter Est. Return
+4.87%
1 Year Est. Return
+21.03%
3 Year Est. Return
+89.14%
5 Year Est. Return
+116.93%
10 Year Est. Return
+716.37%
AUM
$422M
AUM Growth
+$23.2M
Cap. Flow
+$12.1M
Cap. Flow %
2.88%
Top 10 Hldgs %
50.61%
Holding
90
New
9
Increased
55
Reduced
20
Closed
2

Top Buys

Rank Stock Value
1
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
+$6.31M
2
TEAM icon
Atlassian
TEAM
+$3.94M
3
SIVB
SVB Financial Group
SIVB
+$3.18M
4
TFC icon
Truist Financial
TFC
+$2.76M
5
BABA icon
Alibaba
BABA
+$1.68M

Top Sells

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$7.88M
2
MA icon
Mastercard
MA
+$1.81M
3
DD icon
DuPont de Nemours
DD
+$932K
4
AAPL icon
Apple
AAPL
+$791K
5
IDXX icon
Idexx Laboratories
IDXX
+$596K

Sector Composition

Rank Sector Weight
1 Healthcare 37%
2 Technology 17.07%
3 Financials 13.73%
4 Consumer Discretionary 8.79%
5 Communication Services 5.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CHD icon
26
Church & Dwight Co
CHD
$23.4B
$5.21M 1.24%
71,085
+795
+1% +$59.1K
UAA icon
27
Under Armour
UAA
$2.84B
$5.07M 1.2%
199,907
-43
-0% -$1.01K
SO icon
28
Southern Company
SO
$109B
$5.03M 1.19%
89,938
+1,185
+1% +$63.4K
CRM icon
29
Salesforce
CRM
$151B
$4.95M 1.17%
32,637
+522
+2% +$81.8K
XOM icon
30
ExxonMobil
XOM
$644B
$4.93M 1.17%
63,677
+1,055
+2% +$81.7K
BA icon
31
Boeing
BA
$171B
$4.63M 1.1%
12,637
+342
+3% +$125K
TEAM icon
32
Atlassian
TEAM
$25.6B
$4.61M 1.09%
35,225
+32,725
+1,309% +$3.94M
MMM icon
33
3M
MMM
$90.9B
$4.48M 1.06%
30,682
+508
+2% +$78.2K
ABBV icon
34
AbbVie
ABBV
$443B
$4.43M 1.05%
60,921
-3,425
-5% -$269K
BABA icon
35
Alibaba
BABA
$293B
$4.38M 1.04%
25,863
+9,738
+60% +$1.68M
DUK icon
36
Duke Energy
DUK
$97.8B
$4.28M 1.02%
48,030
+1,184
+3% +$105K
GIS icon
37
General Mills
GIS
$19.1B
$3.94M 0.94%
75,086
+1,939
+3% +$100K
AMZN icon
38
Amazon
AMZN
$2.92T
$3.56M 0.85%
37,640
+360
+1% +$33.5K
T icon
39
AT&T
T
$159B
$3.34M 0.79%
132,029
+3,449
+3% +$82.7K
TWLO icon
40
Twilio
TWLO
$30B
$3.11M 0.74%
22,795
+135
+0.6% +$18K
MO icon
41
Altria Group
MO
$114B
$3.04M 0.72%
64,299
+1,955
+3% +$102K
ICPT
42
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$3.03M 0.72%
38,073
+103
+0.3% +$9.22K
BMY icon
43
Bristol-Myers Squibb
BMY
$133B
$2.83M 0.67%
62,303
+2,465
+4% +$115K
TFC icon
44
Truist Financial
TFC
$63.3B
$2.79M 0.66%
+56,315
New +$2.76M
DORM icon
45
Dorman Products
DORM
$3.98B
$2.13M 0.5%
24,435
+715
+3% +$62.1K
DD icon
46
DuPont de Nemours
DD
$18.5B
$1.82M 0.43%
19,302
-7,803
-29% -$932K
HDV
47
iShares Core High Dividend ETF
HDV
$14.5B
$1.34M 0.32%
70,900
+3,025
+4% +$56.7K
GOOG icon
48
Alphabet (Google) Class C
GOOG
$4.36T
$1.32M 0.31%
24,360
-240
-1% -$13.8K
BOC icon
49
Boston Omaha
BOC
$428M
$1.15M 0.27%
49,775
+1,000
+2% +$24.7K
AMRN
50
Amarin Corp
AMRN
$299M
$1.07M 0.25%
2,750
+1,250
+83% +$458K
1
2
3 4

Similar funds

LA
Lifeworks Advisors Grand Rapids, Michigan $779M AUM 21.25% 1-Year Est. Return
SG
SCHF (GPE) Wilson, Wyoming $781M AUM 24.06% 1-Year Est. Return
RTM
RH Tailwind Management West Conshohocken, Pennsylvania $781M AUM
TCMX
Technology Crossover Management X Menlo Park, California $781M AUM 18.39% 1-Year Est. Return
QCMNJ
Quantum Capital Management (New Jersey) Northfield, New Jersey $781M AUM 4.96% 1-Year Est. Return
TIS
Titan Investment Solutions London $781M AUM
MO
McMillan Office St. Clair Shores, Michigan $782M AUM
NCM
Nellore Capital Management Redwood City, California $783M AUM 2.58% 1-Year Est. Return

Biondo Investment Advisors's Q2 2019 Portfolio in Review

As of Q2 2019, Biondo Investment Advisors held 90 positions worth $422M, up 5.8% from $399M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Biondo Investment Advisors's Q2 2019 filing shows 9 new, 55 increased, 20 reduced and 2 closed positions. Its largest new stake was Reata Pharmaceuticals, Inc. Class A Common Stock: 73,090 shares worth $6.9M. The largest sale was Regeneron Pharmaceuticals, an estimated $7.88M.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, down from 38% a quarter earlier, followed by Technology and Financials.

  • Biondo Investment Advisors's largest Q2 2019 buy was Reata Pharmaceuticals, Inc. Class A Common Stock: 73,090 shares worth $6.9M.
  • Biondo Investment Advisors added most to Atlassian in Q2 2019, an estimated $3.94M increase.
  • Biondo Investment Advisors's biggest Q2 2019 reduction was Regeneron Pharmaceuticals, cutting an estimated $7.88M.
  • Biondo Investment Advisors fully exited PrimeEnergy Resources in Q2 2019, selling an estimated $285K.
  • Biondo Investment Advisors's ten largest holdings make up 51% of its $422M portfolio in Q2 2019.
  • Biondo Investment Advisors opened 9 new positions and closed 2 in Q2 2019.
  • Biondo Investment Advisors's portfolio value rose 5.8% quarter-over-quarter to $422M.

Based on Biondo Investment Advisors's 13F filing for Q2 2019, filed 6 Aug 2019.